HLA Markers for Poor Prognosis in Systemic Sclerosis Brazilian Patients
نویسندگان
چکیده
منابع مشابه
HLA Markers for Poor Prognosis in Systemic Sclerosis Brazilian Patients
OBJECTIVES The aim of this study was to evaluate human leukocyte antigen (HLA) involvement in the disease expression and poor prognostic clinical features (pulmonary fibrosis and pulmonary arterial hypertension) in patients diagnosed with systemic sclerosis (SSc) in a multiethnic population. METHODS SSc patients followed up between 2008 and 2011 were included, and clinical data were obtained ...
متن کاملCombined Intratympanic and Systemic Steroid Therapy for Poor-Prognosis Sudden Sensorineural Hearing Loss
Introduction: The aim of this study was to evaluate the efficacy of combined intratympanic and systemic steroid therapy compared with systemic steroid therapy alone in idiopathic sudden sensorineural hearing loss (ISSNHL) patients with poor prognostic factors. Materials and Methods: Seventy-seven patients with sudden sensorineural hearing loss (SSNHL) who had at least one poor prognostic fa...
متن کاملIRF5 polymorphism predicts prognosis in patients with systemic sclerosis.
OBJECTIVE The first genome-wide association study (GWAS) of systemic sclerosis (SSc) demonstrated three non-major histocompatibility complex (MHC) susceptibility loci. The goal of this study was to investigate the impact of these gene variants on survival and severity of interstitial lung disease (ILD) in SSc. METHODS The authors examined 1443 Caucasian SSc patients enrolled in the Genetics v...
متن کاملSystemic inflammatory markers in patients with aortic sclerosis.
The aim of the study was to evaluate several mediators of inflammation in patients with aortic sclerosis in relation to severity of cardiovascular disease. Serum level of cytokines, soluble intracellular adhesion molecule 1, matrix metalloproteinase (MMP) 2 and 9 and their tissue inhibitor TIMP-1, were measured by ELISA and MMPs activity by zymography in 51 aortic sclerosis patients. The increa...
متن کاملMarkers of disease activity in systemic sclerosis.
T he cause of systemic sclerosis (SSc) is still unknown. In the last decade several key events in the pathogenesis have been suggested,’ including the endothelial injury, the fibroblast activation, and the peculiar immunologic involvement.’ The disease starts in the microvascular system, spreading to the connective tissue. * The process involves endothelial cells (EC), lymphocytes, and fibrobla...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Disease Markers
سال: 2013
ISSN: 0278-0240,1875-8630
DOI: 10.1155/2013/301415